Items where authors include "Barton, G."
Article
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736
Wailoo, A. orcid.org/0000-0002-9324-1617, Alava, M.H. orcid.org/0000-0003-4474-5883, Pudney, S. orcid.org/0000-0002-5697-0976 et al. (6 more authors) (2021) An international comparison of EQ-5D-5L and EQ-5D-3L for use in cost-effectiveness analysis. Value in Health, 24 (4). pp. 568-574. ISSN 1098-3015
Kolias, A.G., Edlmann, E., Thelin, E.P. et al. (26 more authors) (2018) Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. Trials, 19. 670. ISSN 1745-6215
Hernandez Alava, M., Wailoo, A. orcid.org/0000-0002-9324-1617, Grimm, S. et al. (7 more authors) (2018) EQ-5D-5L versus EQ-5D-3L: the impact on cost-effectiveness in the United Kingdom. Value in Health, 21 (1). pp. 49-56. ISSN 1098-3015
Macran, S., Wileman, S., Barton, G. et al. (1 more author) (2007) The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire. Quality of Life Research, 16 (2). pp. 331-343. ISSN 0962-9343
Monograph
Hernandez Alava, M., Wailoo, A.J. orcid.org/0000-0002-9324-1617, Grimm, S. et al. (7 more authors) (2017) EQ-5D-5L versus 3L: the impact on cost-effectiveness. Report. ScHARR HEDS Discussion Papers . School of Health and Related Research , University of Sheffield.